-
ljw3 replied to the topic "Restrictions for physician's gifts" – 5 years, 10 months ago
I’d like to add that criteria for giving and receiving gifts often applies to both sides in a lot of company policies. Specifically, my company’s policy is that I am not allowed to receive gifts of any kind, no matter… Read more»
-
ljw3 replied to the topic "Discussion Topic: Course conclusion and impressions" – 5 years, 10 months ago
When I enrolled as this class (which I did as an elective course), I was expecting to learn more about the technical details of the development of different types of devices themselves. I was pleasantly surprised to learn that this… Read more»
-
ljw3 replied to the topic "Recent Examples of Kickback Allegations" – 5 years, 10 months ago
As Juan mentioned, it was pretty easy to dig up an example of a kickback allegation that occured within the pharmaceutical/medical/device industries. Check out this example: http://www.nytimes.com/2013/04/28/opinion/sunday/another-alleged-drug-kickback-scheme.html In this example, Novartis Pharmaceuticals enticed doctors to prescribe their…[Read more]
-
ljw3 replied to the topic "Organizational Behavior Management" – 5 years, 10 months ago
I 100% agree that there should be a good balance of comfort & structure in an organization. I’ve worked in departments on both ends of that spectrum. In a structured department, team members are so uptight and overly professional that… Read more»
-
ljw3 replied to the topic "Discussion Topic: Your organizational type" – 5 years, 10 months ago
I work in a matrix organization and I definitely think I prefer working in that environment. At my company, there are distinct departments within the product development portion of R&D. These include synthetic chemists, analytical chemists, chemical engineers and formulators,… Read more»
-
ljw3 replied to the topic "Forming a Project Team" – 5 years, 10 months ago
I agree with what many others have mentioned so far, that most likely managers do not directly pick their project teams. In that case, as you mentioned, having strategies to deal with conflicts is ideal. I’d like to add that… Read more»
-
ljw3 replied to the topic "Combination Product Phase I clinical Studies" – 5 years, 10 months ago
As a few others have mentioned, technical transfer activities are not completed until a company has fully developed the medical device/drug/combination product and its manufacturing process. This often doesn’t occur until during or after Ph3 clinical trials (and often the… Read more»
-
ljw3 replied to the topic "Minutes for meetings" – 5 years, 10 months ago
As Murad and others have mentioned, meeting minutes are crucial for capturing meetings and holding meeting attendees responsible for decisions and actions. In my opinion, the concept of using meeting minutes is beneficial in every single industry, not just the… Read more»
-
ljw3 replied to the topic "Factors to Consider While making Gantt Chart" – 5 years, 10 months ago
I think that even though Gantt charts are meant to document all of the related activities for a project, I think overall flexibility is key to delivering a project. Sort of related: A common thing that happens at my job… Read more»
-
ljw3 replied to the topic "Discussion Topic: Supplemental on DHF and DMR" – 5 years, 10 months ago
I think the DHF mindset of continuously documenting the “whole story” is more beneficial than the EU approach, where the design is evaluated at a single point in time. I think that documenting the entire development process and rationale for… Read more»
-
ljw3 replied to the topic "Design Controls for Legacy Combination Products" – 5 years, 10 months ago
I agree with you, John. As others have mentioned, companies that have developed legacy products must have some level of documentation on the design and manufacturing processes at minimum. I think that it may be worthwhile to compare their level… Read more»
-
ljw3 replied to the topic "Consequences Of Insufficient Design Controls" – 5 years, 10 months ago
Poor planning can definitely lead to a lack of proper design controls and therefore a medical device lacking in quality, as others have mentioned. As you mentioned in your example, when the people responsible for development & documentation of the… Read more»
-
ljw3 replied to the topic Restrictions for physician's gifts in the forum Consultants and Legal Basics 8 years, 4 months ago
I’d like to add that criteria for giving and receiving gifts often applies to both sides in a lot of company policies. Specifically, my company’s policy is that I am not allowed to receive gifts of any kind, no matter how small. For example, if a vendor sends me flowers to wish me well after an illness for example, I am not allowed to accept…[Read more]
-
ljw3 replied to the topic Discussion Topic: Course conclusion and impressions in the forum Consultants and Legal Basics 8 years, 4 months ago
When I enrolled as this class (which I did as an elective course), I was expecting to learn more about the technical details of the development of different types of devices themselves. I was pleasantly surprised to learn that this course was a more “big picture” lesson in what types of professions are necessary to produce a device. While I…[Read more]
-
ljw3 replied to the topic Recent Examples of Kickback Allegations in the forum Consultants and Legal Basics 8 years, 4 months ago
As Juan mentioned, it was pretty easy to dig up an example of a kickback allegation that occured within the pharmaceutical/medical/device industries.
Check out this example: http://www.nytimes.com/2013/04/28/opinion/sunday/another-alleged-drug-kickback-scheme.html
In this example, Novartis Pharmaceuticals enticed doctors to prescribe their…[Read more]
-
ljw3 replied to the topic Organizational Behavior Management in the forum Organizational Development in Device Companies 8 years, 4 months ago
I 100% agree that there should be a good balance of comfort & structure in an organization. I’ve worked in departments on both ends of that spectrum.
In a structured department, team members are so uptight and overly professional that open discussion in general wasn’t encouraged. This can be detrimental because it is crucial in my opinion to…[Read more]
-
ljw3 replied to the topic Discussion Topic: Your organizational type in the forum Organizational Development in Device Companies 8 years, 4 months ago
I work in a matrix organization and I definitely think I prefer working in that environment. At my company, there are distinct departments within the product development portion of R&D. These include synthetic chemists, analytical chemists, chemical engineers and formulators, for example. Usually a couple people from each of the functional…[Read more]
-
ljw3 replied to the topic Discussion Topic: Your organizational type in the forum Organizational Development in Device Companies 8 years, 4 months ago
I work in a matrix organization and I definitely think I prefer working in that environment. At my company, there are distinct departments within the product development portion of R&D. These include synthetic chemists, analytical chemists, chemical engineers and formulators, for example. Usually a couple people from each of the functional…[Read more]
-
ljw3 replied to the topic Forming a Project Team in the forum Organizational Development in Device Companies 8 years, 4 months ago
I agree with what many others have mentioned so far, that most likely managers do not directly pick their project teams. In that case, as you mentioned, having strategies to deal with conflicts is ideal. I’d like to add that one tip that was given to me by a senior project leader was even though you may not like or agree with every team member,…[Read more]
-
ljw3 replied to the topic Combination Product Phase I clinical Studies in the forum Introduction to Design Controls 8 years, 4 months ago
As a few others have mentioned, technical transfer activities are not completed until a company has fully developed the medical device/drug/combination product and its manufacturing process. This often doesn’t occur until during or after Ph3 clinical trials (and often the timeline depends on how risk averse the company is, i.e. some companies…[Read more]
- Load More